Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Med Care. 2013 Oct;51(10):894–900. doi: 10.1097/MLR.0b013e31829fafdc

Table 3.

Adjusted rates of the probability of changing medications and the probability of having a gap in medication use among dually-eligible nursing home residents by coverage status and presence of prior authorization or step therapy requirements, 2006–2008

2006 2007 and 2008 2006 2007 and 2008
Covered Not
Covered
P-value Covered Not
Covered
P-value No PA
or Step
PA or
Step
P-value No PA
or Step
PA or
Step
P-Value
Adj.
Rate
Adj.
Rate
Adj.
Rate
Adj.
Rate
Adj.
Rate
Adj.
Rate
Adj.
Rate
Adj.
Rate
ARBs
Change 0.11 0.35 <0.0001* 0.06 0.30 <0.0001* 0.11 0.35 <0.0001* 0.08 0.09 0.54
Gap 0.21 0.30 <0.0001* 0.18 0.36 <0.0001* 0.20 0.38 <0.0001* 0.18 0.22 0.03
Cholinesterase Inhibitors
Change 0.06 0.12 <0.0001* 0.05 0.17 <0.0001* 0.07 0.06 0.02 0.05 0.12 <0.0001*
Gap 0.24 0.35 <0.0001* 0.17 0.22 0.31 0.22 0.35 <0.0001* 0.17 0.18 0.70
Opioids
Change 0.24 0.32 0.0002 0.17 0.39 0.02 0.25 0.20 0.004 0.17 0.15 0.39
Gap 0.27 0.41 <0.0001* 0.22 0.27 0.52 0.28 0.28 0.99 0.22 0.23 0.46
Osteoporosis Medications
Change 0.18 0.40 <0.0001* 0.05 0.79 0.0001* 0.18 0.29 <0.0001* 0.05 0.15 <0.0001*
Gap 0.33 0.40 0.26 0.24 0.55 0.02 0.33 0.38 0.01 0.24 0.23 0.47
Anti-depressants
Change 0.20 0.37 <0.0001* 0.13 0.48 <0.0001* 0.21 0.24 0.03 0.13 0.17 0.0002
Gap 0.18 0.22 <0.0001* 0.15 0.32 <0.0001* 0.18 0.20 0.20 0.15 0.16 0.61
Anti-psychotics
Change 0.14 0.22 0.02 -- -- -- 0.14 0.14 0.84 0.09 0.17 <0.0001*
Gap 0.25 0.35 0.03 -- -- -- 0.26 0.24 0.07 0.20 0.22 0.16
*

Results that remain statistically significant after correcting for multiple comparisons using the Bonferroni correction.

Notes: Prior authorization and step therapy are only required for covered drugs, so we assess whether prior authorization or step therapy was required conditional on plan coverage. We were unable to estimate models for atypical antipsychotic users in 2007/2008 due to a very small number of individuals whose atypical antipsychotic medication was not covered by their new plan.